NCT01636739已完成不适用
Special Drug Use Investigation for ROTARIX
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 10,982
- 主要终点
- Determination of the incidence of IS
研究概览
简要总结
This study aims to determine the incidence of intussusceptions (IS) (including suspected cases of intussusception) after vaccination with Oral Rotarix® under clinical practice, in Japan.
详细描述
This is non-interventional study conducted in one group received Oral Rotarix®.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Infants who receive Rotarix for the first time to prevent rotavirus gastroenteritis, an indication of Rotarix, will be included in the investigation.
排除标准
- •All infants included in the drug use investigation of Oral Rotarix will be excluded.
结局指标
主要结局
Determination of the incidence of IS
时间窗: On the 1 year birthday of the subject
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
Special Investigation For Long Term Use Of Tolterodine (Regulatory Post Marketing Commitment Plan).Urinary Bladder, OveractiveNCT00795509Pfizer374
招募中
不适用
Sarclisa Specified Drug Use Investigation (Monotherapy / with Dexamethasone / with Carfilzomib and Dexamethasone) (Relapsed or refractory multiple myeloma)Relapsed or refractory multiple myelomaJPRN-UMIN000047806Sanofi K.K.86
已完成
不适用
Special Investigation For Long-Term Use Of Sildenafil (Regulatory Post Marketing Commitment Plan)Pulmonary HypertensionNCT00666198Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3,337
已完成
不适用
Special Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)Respiratory DisordersNCT01395862GlaxoSmithKline1,001
已完成
不适用
Special Investigation in Patients With Crohn's Disease (All Patients Investigation)Crohn's DiseaseNCT01298648AbbVie (prior sponsor, Abbott)1,716